NCT04414813View on ClinicalTrials.gov

Stereotactic Transplantation of hAESCs for Parkinson's Disease

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

October 8, 2020

Primary Completion Date

February 8, 2023

Study Completion Date

February 8, 2023

Conditions
Parkinson's Disease
Interventions
BIOLOGICAL

Human Amniotic Epithelial Stem Cells

Stereotactic transplantation of hAESCs for participants with PD.

Trial Locations (1)

200000

WU Jingwen, Shanghai

All Listed Sponsors
collaborator

Shanghai iCELL Biotechnology Co., Ltd, Shanghai, China

INDUSTRY

lead

Shanghai East Hospital

OTHER

NCT04414813 - Stereotactic Transplantation of hAESCs for Parkinson's Disease | Biotech Hunter | Biotech Hunter